4.5 Article

Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality

Journal

JOURNAL OF CARDIAC FAILURE
Volume 22, Issue 11, Pages 891-900

Publisher

CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
DOI: 10.1016/j.cardfail.2016.06.005

Keywords

Heart failure; Clostridium difficile; hospitalization; outcomes

Funding

  1. Spectrum, Clinical and Translational Science Award (CTSA) program - National Center for Advancing Translational Sciences at the National Institutes of Health (NIH) [UL1 TR001085]
  2. NIH/NIA [1K08AG04442801A1]

Ask authors/readers for more resources

Background: Patients with heart failure (HF) are frequently hospitalized with common bacterial infections. It is unknown whether they experience concomitant Clostridium difficile infection (CDI) more frequently than patients without HF, and whether CDI affects their mortality. Methods: We used 2012 National Inpatient Sample data to determine the rate of CDI and associated in hospital mortality for hospitalized patients with comorbid HF and urinary tract infection (UTI), pneumonia (PNA), or sepsis. Univariate and multivariate analyses were performed. Weighted data are presented. Results: There were an estimated 5,851,582 patient hospitalizations with discharge diagnosis of UTI, PNA, or sepsis in 2012 in the United States. Of these, 23.4% had discharge diagnosis of HF. Patients with HF were on average older and had more comorbidities. CDI rates were higher in hospitalizations with discharge diagnosis of HF compared with those without HF (odds ratio 1.13, 95% confidence interval 1.10-1.16) after controlling for patient demographics and comorbidities and hospital characteristics. Among HF hospitalizations with UTI, PNA, or sepsis, those with concomitant CDI had a higher in-hospital mortality than those without concomitant CDI (odds ratio 1.81, 95% confidence interval 1.71-1.92) after controlling for the covariates outlined previously. Conclusions: HF is associated with higher CDI rates among hospitalized patients with other common bacterial infections, even when adjusting for other known risk factors for CDI. Among these patients with comorbid HF, CDI is associated with markedly higher in-hospital mortality. These findings may suggest an opportunity to improve outcomes for hospitalized patients with HF and common bacterial infections, possibly through improved Clostridium difficile screening and prophylaxis protocols.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cardiac & Cardiovascular Systems

Pursuing Equity in Performance Measurement

Paul Heidenreich, Alexander Sandhu

CIRCULATION (2023)

Letter Cardiac & Cardiovascular Systems

Updating the Accuracy of Administrative Claims for Identifying Left Ventricular Ejection Fraction Among Patients With Heart Failure

Alexander T. Sandhu, Jimmy Zheng, Megan Skye, Paul A. Heidenreich

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2023)

Article Cardiac & Cardiovascular Systems

Evaluating the Implementation of Patient-Reported Outcomes in Heart Failure Clinic: A Qualitative Assessment

Cati Brown-Johnson, Jamie Calma, Alexis Amano, Marcy Winget, Sonia R. Harris, Stacie Vilendrer, Steve M. Asch, Paul Heidenreich, Alexander T. Sandhu, Neil M. Kalwani

Summary: This study evaluated clinician perceptions of the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) and found that it enhanced multiple aspects of heart failure patient care. Most clinicians reported that the KCCQ-12 was acceptable, appropriate, and useful in clinical care. To promote further implementation, efforts should focus on clinician engagement, streamline electronic health record integration, and provide staff education.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2023)

Article Cardiac & Cardiovascular Systems

Long-Term Outcomes of Early Coronary Artery Disease Testing After New-Onset Heart Failure

Jimmy Zheng, Paul A. Heidenreich, Shun Kohsaka, William F. Fearon, Alexander T. Sandhu

Summary: CAD testing remains underutilized in patients with newly diagnosed HF. Early CAD evaluation in patients with incident HF is associated with improved clinical management and long-term outcomes, including reduced all-cause mortality.

CIRCULATION-HEART FAILURE (2023)

Letter Endocrinology & Metabolism

Administrative Coding Versus Laboratory Diagnosis of Inpatient Hypoglycemia

Robert J. Gallo, Daniel Z. Fang, Paul A. Heidenreich

DIABETES CARE (2023)

Review Cardiac & Cardiovascular Systems

Pharmacist- and Nurse-Led Medical Optimization in Heart Failure: A Systematic Review and Meta-Analysis

Jimmy Zheng, Thomas Mednick, Paula. Heidenreich, Alexander T. Sandhu

Summary: This study aimed to investigate the associations of nonphysician provider-led guideline-directed medical therapy (GDMT) interventions with therapy use and clinical outcomes. The findings showed that pharmacist- and nurse-led interventions improved guideline concordance and increased the initiation and uptitration of therapies. Further research is needed to evaluate newer therapies and titration strategies integrated with pharmacist and/or nurse-based care.

JOURNAL OF CARDIAC FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Opportunities for Change in Home Health Care in Heart Failure

Aradhana Verma, Paul A. Heidenreich, Boback Ziaeian

JACC-HEART FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

The Value of Comprehensive Guideline-Directed Therapy for Heart Failure With Reduced Ejection Fraction

Dhruv S. Kazi, Paul Heidenreich

JACC-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US The Get With The Guidelines-Heart Failure Registry

Jacob B. Pierce, Muthiah Vaduganathan, Gregg C. Fonarow, Uchechukwu Ikeaba, Karen Chiswell, Javed Butler, Adam D. DeVore, Paul A. Heidenreich, Joanna C. Huang, Michelle M. Kittleson, Karen E. Joynt Maddox, Karthik K. Linganathan, James J. McDermott, Anjali Tiku Owens, Pamela N. Peterson, Scott D. Solomon, Orly Vardeny, Clyde W. Yancy, Stephen J. Greene

Summary: The use of SGLT2 inhibitors (SGLT2i) for patients with heart failure with reduced ejection fraction (HFrEF) is recommended by clinical guidelines. However, the adoption of SGLT2i in the US is unknown. This study found that the prescription rate of SGLT2i for eligible HFrEF patients in the US is low, with significant variation among hospitals.

JAMA CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registry

Neil Keshvani, Sonia Shah, Iyanuoluwa Ayodele, Karen Chiswell, Brooke Alhanti, Larry A. Allen, Stephen J. Greene, Clyde W. Yancy, Windy W. Alonso, Harriette G. C. Van Spall, Gregg C. Fonarow, Paul A. Heidenreich, Ambarish Pandey

Summary: Sex differences in long-term outcomes following hospitalization for heart failure (HF) were evaluated in this study. The findings showed that females had a higher risk of rehospitalization compared to males after 5 years of follow-up.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America

Biykem Bozkurt, Tariq Ahmad, Kevin M. Alexander, William L. Baker, Kelly Bosak, Khadijah Breathett, Gregg C. Fonarow, Paul Heidenreich, Jennifer E. Ho, Eileen Hsich, Nasrien E. Ibrahim, Lenette M. Jones, Sadiya S. Khan, Prateeti Khazanie, Todd Koelling, Harlan M. Krumholz, Kiran K. Khush, Christopher Lee, Alanna A. Morris, Robert L. Page, Ambarish Pandey, Mariann R. Piano, Josef Stehlik, Lynne Warner Stevenson, John R. Teerlink, Muthiah Vaduganathan, Boback Ziaeian

JOURNAL OF CARDIAC FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Myocardial Infarction Across COVID-19 Pandemic Phases: Insights From the Veterans Health Affairs System

Celina M. M. Yong, Laura Graham, Tariku J. J. Beyene, Shirin Sadri, Juliette Hong, Tom Burdon, William F. F. Fearon, Steven M. M. Asch, Mintu Turakhia, Paul Heidenreich

Summary: During the COVID-19 pandemic, cardiovascular procedural treatments for NSTEMI patients were deferred, with uncertain impact on patient outcomes.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction

Rishi V. Parikh, Alan S. Go, Ankeet S. Bhatt, Thida C. Tan, Amanda R. Allen, Kent Y. Feng, Steven A. Hamilton, Andrew S. Tai, Jesse K. Fitzpatrick, Keane K. Lee, Sirtaz Adatya, Harshith R. Avula, Dana R. Sax, Xian Shen, Joaquim Cristino, Alexander T. Sandhu, Paul A. Heidenreich, Andrew P. Ambrosy

Summary: The study developed predictive models based on electronic health records for worsening heart failure events across different left ventricular ejection fraction categories. Despite differences in underlying heart failure causes, the performance and predictors of the models were found to be similar across various categories.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Should Beta-Blockers Be Used in Heart Failure If the LVEF Is Not Reduced?

Paul A. Heidenreich, John J. V. Mcmurray

JACC-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Deep Learning of Electrocardiograms in Sinus Rhythm From US Veterans to Predict Atrial Fibrillation

Neal Yuan, Grant Duffy, Sanket S. Dhruva, Adam Oesterle, Cara N. Pellegrini, John Theurer, Marzieh Vali, Paul A. Heidenreich, Salomeh Keyhani, David Ouyang

Summary: Deep learning applied to outpatient ECGs in sinus rhythm can predict the occurrence of atrial fibrillation in a large and diverse patient population.

JAMA CARDIOLOGY (2023)

No Data Available